Lack of Detection of Human Papillomavirus DNA in Prostate Carcinomas in Patients from Northeastern Brazil

Overview

Journal Genet Mol Biol

Specialty Genetics

Date 2016 Mar 24

PMID 27007894

Citations 5

Authors

Ari P Araujo-Neto

Hygor Ferreira-Fernandes

Carolina M M Amaral

Lina G Santos

Antonio C Freitas

Jacinto C Silva-Neto

Juan A Rey

Rommel R Burbano

Benedito B da Silva

France K N Yoshioka

Giovanny R Pinto

Affiliations

Soon will be listed here.

Abstract

Prostate cancer is the second most common cancer among men in western populations, and despite its high mortality, its etiology remains unknown. Inflammatory processes are related to the etiology of various types of tumors, and prostate inflammation, in particular, has been associated with prostate cancer carcinogenesis and progression. Human papillomavirus (HPV) is associated with benign and malignant lesions in the anogenital tract of both females and males. The possible role of HPV in prostate carcinogenesis is a subject of great controversy. In this study, we aimed to examine the prevalence of HPV infections in prostate carcinomas of patients from northeastern Brazil. This study included 104 tissue samples from primary prostate carcinoma cases. HPV DNA was purified and then amplified using MY09/11 and GP5+/GP6+ degenerate primer sets that detect a wide range of HPV types, and with specific PCR primers sets for E6 and E7 HPV regions to detect HPV 16. None of the samples showed amplification products of HPV DNA for primer sets MY09/11 and GP5+/GP6+, or the specific primer set for the E6 and E7 HPV regions. HPV infection, thus, does not seem to be one of the causes of prostate cancer in the population studied.

Citing Articles

Does Human Papillomavirus Play a Causative Role in Prostate Cancer? A Systematic Review Using Bradford Hill's Criteria.

Bello R, Willis-Powell L, James O, Sharma A, Marsh E, Ellis L Cancers (Basel). 2023; 15(15).

PMID: 37568712 PMC: 10416874. DOI: 10.3390/cancers15153897.

Presence of HPV in prostate tissue from patients submitted to prostate biopsy.

Pereira N, Martins E, Quintela M, Cunha A, Santos Netto M, Waisberg J Acta Cir Bras. 2023; 37(12):e371205.

PMID: 36651430 PMC: 9839154. DOI: 10.1590/acb371205.

Correlative analysis of the expression of IL-10 and Ki-67 in human cervical cancer and cervical intraepithelial neoplasias and human papillomavirus infection.

Min Z, Pu X, Gu Z Oncol Lett. 2018; 16(6):7189-7194.

PMID: 30546456 PMC: 6256322. DOI: 10.3892/ol.2018.9520.

Association between Human Papillomavirus and Non-cervical Genital Cancers in Brazil: A Systematic Review and Meta-Analysis.

de Peder L, da Silva C, Boeira V, Plewka J, Turkiewicz M, Consolaro M Asian Pac J Cancer Prev. 2018; 19(9):2359-2371.

PMID: 30255688 PMC: 6249444. DOI: 10.22034/APJCP.2018.19.9.2359.

Human Papilloma Virus Detection by INNOLiPA HPV in Prostate Tissue from Men of Northeast Mexico.

Davila-Rodriguez M, Ignacio Morales C, Aragon Tovar A, Olache Jimenez D, Castelan Maldonado E, Lara Miranda S Asian Pac J Cancer Prev. 2016; 17(11):4863-4865.

PMID: 28030912 PMC: 5454687. DOI: 10.22034/APJCP.2016.17.11.4863.

References

Yow M, Tabrizi S, Severi G, Bolton D, Pedersen J, Longano A . Detection of infectious organisms in archival prostate cancer tissues. BMC Cancer. 2014; 14:579. PMC: 4132904. DOI: 10.1186/1471-2407-14-579. View

Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R . Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996; 34(9):2095-100. PMC: 229196. DOI: 10.1128/jcm.34.9.2095-2100.1996. View

Terris M, Peehl D . Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology. 1997; 50(1):150-6. DOI: 10.1016/S0090-4295(97)00126-X. View

Dodd J, PARASKEVAS M, McNicol P . Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol. 1993; 149(2):400-2. DOI: 10.1016/s0022-5347(17)36103-7. View

Rabkin C, Biggar R, Melbye M, Curtis R . Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol. 1992; 136(1):54-8. DOI: 10.1093/oxfordjournals.aje.a116420. View

Michopoulou V, Derdas S, Symvoulakis E, Mourmouras N, Nomikos A, Delakas D . Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients. Tumour Biol. 2014; 35(12):12765-73. DOI: 10.1007/s13277-014-2604-7. View

Geronimo Silva Jr R, Silva B . No evidence for an association of human papillomavirus and breast carcinoma. Breast Cancer Res Treat. 2010; 125(1):261-4. DOI: 10.1007/s10549-010-1129-z. View

Vesco K, Whitlock E, Eder M, Burda B, Senger C, Lutz K . Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011; 155(10):698-705, W216. DOI: 10.7326/0003-4819-155-10-201111150-00377. View

Gazzaz F, Mosli H . Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J. 2009; 30(5):633-7. View

10.

Conceicao M, Boing A, Peres K . Time trends in prostate cancer mortality according to major geographic regions of Brazil: an analysis of three decades. Cad Saude Publica. 2014; 30(3):559-66. DOI: 10.1590/0102-311x00005813. View

11.

Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M . Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res. 1992; 52(21):5991-6. View

12.

Bergh J, Marklund I, Gustavsson C, Wiklund F, Gronberg H, Allard A . No link between viral findings in the prostate and subsequent cancer development. Br J Cancer. 2006; 96(1):137-9. PMC: 2360195. DOI: 10.1038/sj.bjc.6603480. View

13.

Tachezy R, Hrbacek J, Heracek J, Salakova M, Smahelova J, Ludvikova V . HPV persistence and its oncogenic role in prostate tumors. J Med Virol. 2012; 84(10):1636-45. DOI: 10.1002/jmv.23367. View

14.

McNicol P, Dodd J . Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol. 1990; 28(3):409-12. PMC: 269632. DOI: 10.1128/jcm.28.3.409-412.1990. View

15.

Ayres A, Azevedo E Silva G . Cervical HPV infection in Brazil: systematic review. Rev Saude Publica. 2010; 44(5):963-74. DOI: 10.1590/s0034-89102010000500023. View

16.

Adami H, Kuper H, Andersson S, Bergstrom R, Dillner J . Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2003; 12(9):872-5. View

17.

Freire M, Pires D, Forjaz R, Sato S, Cotrim I, Stiepcich M . Genital prevalence of HPV types and co-infection in men. Int Braz J Urol. 2014; 40(1):67-71. DOI: 10.1590/S1677-5538.IBJU.2014.01.10. View

18.

Chen A, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D . Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res. 2011; 17(3):613-7. DOI: 10.1007/s12253-010-9357-4. View

19.

Aghakhani A, Hamkar R, Parvin M, Ghavami N, Nadri M, Pakfetrat A . The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis. 2010; 43(1):64-9. DOI: 10.3109/00365548.2010.502904. View

20.

Singh N, Hussain S, Kakkar N, Singh S, Sobti R, Bharadwaj M . Implication of high risk human papillomavirus HR-HPV infection in prostate cancer in Indian population--a pioneering case-control analysis. Sci Rep. 2015; 5:7822. PMC: 4296305. DOI: 10.1038/srep07822. View